Treatment with banked 3rd party donor derived virus specific T cells: The advantages of pre-defined HLA restriction and epitope specificity Meeting Abstract


Authors: Prockop, S.; Doubrovina, E.; Hasan, A.; O'Reilly, R. J.
Abstract Title: Treatment with banked 3rd party donor derived virus specific T cells: The advantages of pre-defined HLA restriction and epitope specificity
Meeting Title: ISCT 2020 Paris Virtual
Journal Title: Cytotherapy
Volume: 22
Issue: 5 Suppl.
Meeting Dates: 2020 May 28-29
Meeting Location: Virtual
ISSN: 1465-3249
Publisher: Elsevier Science Ltd.  
Date Published: 2020-05-01
Start Page: S135
Language: English
ACCESSION: WOS:000536174900300
PROVIDER: wos
DOI: 10.1016/j.jcyt.2020.03.266
Notes: Meeting Abstract: 263 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Susan E Prockop
    262 Prockop
  2. Richard O'Reilly
    747 O'Reilly